TABLE 1.

Demographics and Population Characteristics at Baseline and End of Project

	Baseline(May 2018)	End of Project (December 2019)	P
Total patients per quality measure, n	2,559	3,304	—
Male	1,257 (49.12)	1,544 (46.73)	0.63
Female	1,302 (50.88)	1,760 (53.27)	0.08
Mean age, years	56.31	56.8	0.158
Median age, years	59	59	—
Type of diabetes
Type 1	411 (16.06)	445 (13.47)	0.006
Type 2	1,842 (71.98)	2,278 (68.95)	0.011
Other*	306 (11.96)	581 (17.58)	<0.001
≥1 A1C value in past 12 months	2,305 (90.07)	3,204 (96.97)	<0.001
A1C ≤9% in past 12 months	1,882 (73.54)	2,778 (84.08)	<0.001
A1C >9% in last 12 months	423 (16.53)	426 (12.89)	<0.001
Missing A1C in last 12 months	254 (9.93)	100 (3.03)	<0.001
Mean A1C at population level, %	7.6	7.41	<0.001
LDL cholesterol <100 mg/dL in past 12 months	1,443 (56.39)	1,867 (56.51)	0.97
Mean LDL cholesterol, mg/dL	83.12	82.33	0.3
On statin	1,804 (70.50)	2,286 (69.19)	0.25
Blood pressure <140/90 mmHg in past 12 months	1,727 (67.49)	2,372 (71.79)	<0.001
UACR in past 12 months	1,258 (49.16)	1,845 (55.84)	0.892
UACR <30 mg/g	884 (34.54)	1,249 (37.80)	0.12
A1C <7%, blood pressure <140/90 mmHg, and LDL cholesterol <130 mg/dL	648 (25.32)	1,023 (30.96)	<0.001
Current retinopathy screening	1,651 (64.52)	2,348 (71.07)	<0.001

Data are n (%) unless otherwise noted. Quality measure definition: patients were aged 18–75 years and had at least one visit in the past 12 months for diabetes management. *Nonspecified type of diabetes included drug-induced hyperglycemia, exocrine pancreas dysfunction, and genetic syndromes. UACR, urine albumin-to-creatinine ratio.